{"title":"DNA methyltransferase inhibition leading to population decline (4)","keyEvents":[{"id":1366,"type":"key-event"},{"id":1619,"type":"molecular-initiating-event"},{"id":328,"type":"adverse-outcome"},{"id":360,"type":"adverse-outcome"},{"id":1777,"type":"key-event"},{"id":1776,"type":"key-event"},{"id":1766,"type":"key-event"},{"id":1774,"type":"key-event"}],"id":339,"stressors":[{"name":"5-Azacytidine","qualityAssurance":"High","chemicalId":20116,"inchiKey":"NMUSYJAQQFHJEW-KVTDHHQDSA-N","preferredName":"5-Azacytidine","synonyms":["5AzaC\n","1,3,5-Triazin-2(1H)-one, 4-amino-1-β-D-ribofuranosyl-\n","2-(β-D-ribofurannosyl)-4-amino-1,3,5-triazine-2-one\n","2-(β-D-ribofuranosil)-4-amino-1,3,5-triazin-2-ona\n","2-(β-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-on\n","2-(β-D-ribofuranosyl)-4-amino-1,3,5-triazin-2-one\n","Antibiotic U 18496\n","Azacitidine\n","Azacytidine\n","Ladakamycin\n","Ledakamycin\n","Mylosar\n","NSC 102816\n","NSC 103-627\n","s-Triazin-2(1H)-one, 4-amino-1-β-D-ribofuranosyl-\n"]}]}
{"title":"5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase","keyEvents":[{"id":626,"type":"key-event"},{"id":619,"type":"molecular-initiating-event"},{"id":1164,"type":"adverse-outcome"},{"id":1163,"type":"key-event"},{"id":1255,"type":"key-event"},{"id":621,"type":"key-event"},{"id":1142,"type":"key-event"},{"id":1161,"type":"key-event"}],"id":195,"stressors":[{"name":"Fluvoxamine","qualityAssurance":"Not Specified","chemicalId":44002,"inchiKey":"CJOFXWAVKWHTFT-XSFVSMFZSA-N","preferredName":"Fluvoxamine","synonyms":["1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-\n"]}]}
